Susquehanna Portfolio Strategies »

Ligand Pharmaceuticals In shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 5.8k 177.14
2025-06-30 $204k 1.8k 113.68

More positions owned by Susquehanna Portfolio Strategies

Oracle Corporation (ORCL)
Apple (AAPL)
Blackrock (BLK)
Merck & Co (MRK)
Arista Networks Com Shs (ANET)
Pfizer (PFE)
Amazon (AMZN)
Simon Property (SPG)
Baker Hughes Company Cl A (BKR)
Realty Income (O)
American Express Company (AXP)
Chipotle Mexican Grill (CMG)
Vulcan Materials Company (VMC)
General Motors Company (GM)
MetLife (MET)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
Macquarie Group
State Street Corporation
Congress Asset Management
Chicago Capital
Stephens Investment Management Group
Massachusetts Financial Services
Dimensional Fund Advisors
Geode Capital Management
FMR
Loomis, Sayles and
Invesco
Ubs Global Asset Management Americas

View all funds holding Ligand Pharmaceuticals In